An HHS watchdog found hospitals wrongly billed Medicare for up to $25 million in cancer treatments, accounting for a nearly 25% bump in their bundled payments.
A major player in 340B drug discount reforms, Rep. Chris Collins (R-N.Y.) can't serve on the House Energy & Commerce Committee, a key health committee, until federal charges of insider trading are resolved.
The emergency department at the Indian Health Service hospital on the Rosebud Sioux Indian Reservation is under scrutiny again.
Some doctors at William Beaumont Hospital in Royal Oak, Mich., were given lucrative perks, paid in excess of $700,000 annually, given the use of hospital employees for their office practice—and still allowed to bill insurers, the government and patients themselves.
Beaumont Health has agreed to pay an $84.5 million settlement to the U.S. Justice Department, state of Michigan and four whistleblowers for violating federal laws that bar hospitals from overcompensating physicians and filing false claims.
California's insurance commissioner urged the U.S. Department of Justice to sue to block the $69 billion proposed merger between CVS Health and Aetna arguing, among other things, the companies have not committed to lowering health insurance premiums.
The CMS has not complied with a section of MACRA that requires it to impose prior authorization for chiropractic services, a government watchdog found. Chiropractors have one of the highest rates of improper payments in Medicare.
The CMS isn't doing enough to ensure that states are adequately paying managed Medicaid companies and that the plans are making correct payments to providers, according to the GAO.
New Jersey insurance regulators fined UnitedProject Japan $2.5 million for several insurance law violations, including sending patients to a provider of hemophilia services that hadn't been approved by the state.
An addiction treatment representative urged House lawmakers to consider legislation to help stop patient-brokering fraud, but policymaking on the issue is complicated by states' regulatory roles.
The Food and Drug Administration is forming a task force to find ways to improve the supply of crucial drugs. It's a new approach for the drug regulator, which has no control over companies.
Massachusetts' attorney general is heightening scrutiny of the proposed merger between Beth Israel Deaconess Medical Center and Lahey Health, saying she's concerned it would raise healthcare costs and impede access.